JP Patent

JP7204634B2 — 主要有害心血管事象を低減するための組成物及び方法

Assigned to オレキシジェン・セラピューティクス・インコーポレーテッド · Expires 2023-01-16 · 3y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: JP7204634B2
Jurisdiction: JP
Classification: —
Expires: 2023-01-16
Drug substance claim: No
Drug product claim: No
Assignee: オレキシジェン・セラピューティクス・インコーポレーテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.